Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries

Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries

Abstract Background Patients with rheumatoid arthritis (RA) have an increased risk of infection and malignancy compared with the general population. Infection risk is increased further with the use of disease-modifying antirheumatic drugs (DMARDs), whereas evidence on whether the use of biologic DMA...

Full description

Bibliographic Details
Main Authors: Alyssa Dominique, Merete Lund Hetland, Axel Finckh, Jacques-Eric Gottenberg, Florenzo Iannone, Roberto Caporali, Tzuyung Douglas Kou, Dan Nordstrom, Maria Victoria Hernandez, Carlos Sánchez-Piedra, Fernando Sánchez-Alonso, Karel Pavelka, T. Christopher Bond, Teresa A. Simon
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Arthritis Research & Therapy
Subjects:
Rheumatoid arthritis
Abatacept
Biologic DMARD
Safety
Infections
Malignancy
Online Access:https://doi.org/10.1186/s13075-023-03067-x

Internet

https://doi.org/10.1186/s13075-023-03067-x

Similar Items